nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin/platelet ratio
|
Feng, Cuicui |
|
|
103 |
3 |
p. 715-723 |
artikel |
2 |
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management
|
Marra, John Donald |
|
|
103 |
3 |
p. 1013-1014 |
artikel |
3 |
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
|
Leoni, Simona |
|
|
103 |
3 |
p. 1025-1026 |
artikel |
4 |
A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters
|
Aksu, Ayşegül |
|
|
103 |
3 |
p. 813-822 |
artikel |
5 |
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)
|
Vallejo, Carlos |
|
|
103 |
3 |
p. 705-713 |
artikel |
6 |
Appropriate timing to perform an interim 18F-FDG PET/CT in patients with nasal-type extranodal natural killer/T cell lymphoma
|
Wang, Rang |
|
|
103 |
3 |
p. 885-892 |
artikel |
7 |
Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation
|
Tsushima, Takafumi |
|
|
103 |
3 |
p. 935-946 |
artikel |
8 |
Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia
|
Huang, Pengli |
|
|
103 |
3 |
p. 729-736 |
artikel |
9 |
Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS
|
Cao, Zheng |
|
|
103 |
3 |
p. 869-883 |
artikel |
10 |
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
|
Akyildiz, Arif |
|
|
103 |
3 |
p. 905-915 |
artikel |
11 |
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia
|
Ahmed, Heba A. |
|
|
103 |
3 |
p. 781-792 |
artikel |
12 |
Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation
|
Strasser, Bernhard |
|
|
103 |
3 |
p. 1011-1012 |
artikel |
13 |
Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study
|
Giladi, Odil |
|
|
103 |
3 |
p. 803-811 |
artikel |
14 |
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
|
Demel, Ivo |
|
|
103 |
3 |
p. 981-992 |
artikel |
15 |
Effect of low skeletal muscle mass on NK cells in patients with acute myeloid leukemia and its correlation with prognosis
|
Cui, Jialin |
|
|
103 |
3 |
p. 771-780 |
artikel |
16 |
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
|
Marchesi, Francesco |
|
|
103 |
3 |
p. 947-956 |
artikel |
17 |
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
|
Zhou, Huixing |
|
|
103 |
3 |
p. 855-868 |
artikel |
18 |
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study
|
Okubo, So |
|
|
103 |
3 |
p. 823-831 |
artikel |
19 |
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
|
Garrote, Marta |
|
|
103 |
3 |
p. 737-747 |
artikel |
20 |
Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab
|
Lucijanic, Marko |
|
|
103 |
3 |
p. 1015-1016 |
artikel |
21 |
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
|
Gabellier, Ludovic |
|
|
103 |
3 |
p. 759-769 |
artikel |
22 |
Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut
|
Vegas Villalmanzo, Blanca |
|
|
103 |
3 |
p. 725-727 |
artikel |
23 |
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
|
Wang, Qiuyan |
|
|
103 |
3 |
p. 999-1005 |
artikel |
24 |
Midostaurin for FLT3-mutated AML: a real-world analysis of effectiveness and infection risk at a single center
|
Kennedy, Alice |
|
|
103 |
3 |
p. 1031-1033 |
artikel |
25 |
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
|
Zhao, Yifan |
|
|
103 |
3 |
p. 969-980 |
artikel |
26 |
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia
|
Shang, Chun-Yu |
|
|
103 |
3 |
p. 833-841 |
artikel |
27 |
Optimal dosage of rituximab for children with Burkitt lymphoma
|
Huang, Shuang |
|
|
103 |
3 |
p. 893-903 |
artikel |
28 |
Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript
|
Dereme, Julien |
|
|
103 |
3 |
p. 1027-1029 |
artikel |
29 |
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort
|
Pei, Yuanyuan |
|
|
103 |
3 |
p. 695-703 |
artikel |
30 |
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia
|
Ishida, Hisashi |
|
|
103 |
3 |
p. 843-854 |
artikel |
31 |
Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine
|
Lv, Kebing |
|
|
103 |
3 |
p. 1017-1019 |
artikel |
32 |
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival
|
Chattopadhyay, Sohini |
|
|
103 |
3 |
p. 749-758 |
artikel |
33 |
Small lymphocytic lymphoma infiltrating gastrointestinal tract and mimicking inflammatory bowel disease, successfully treated with acalabrutinib
|
Krečak, Ivan |
|
|
103 |
3 |
p. 1021-1023 |
artikel |
34 |
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients
|
Heybati, Kiyan |
|
|
103 |
3 |
p. 957-967 |
artikel |
35 |
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping
|
Wu, Xiaojin |
|
|
103 |
3 |
p. 917-933 |
artikel |
36 |
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study
|
Sun, Peng |
|
|
103 |
3 |
p. 793-801 |
artikel |
37 |
VEXAS syndrome: complete molecular remission after hypomethylating therapy
|
Sockel, Katja |
|
|
103 |
3 |
p. 993-997 |
artikel |
38 |
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab
|
Gong, Yuemin |
|
|
103 |
3 |
p. 1007-1009 |
artikel |